InvestorsHub Logo
Followers 826
Posts 119467
Boards Moderated 15
Alias Born 09/05/2002

Re: vinmantoo post# 2256

Wednesday, 06/22/2022 2:41:43 PM

Wednesday, June 22, 2022 2:41:43 PM

Post# of 2933
The Canada approval is for the pediatric market (age 3-11). Mavyret was already approved in Canada for adults and adolescents.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ENTA News